Dugaduga, Raquel .
HRN: 28-54-77 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/16/2026
CO-AMOXICLAV 625MG (TAB)
03/16/2026
03/22/2026
PO
1tab
Bid
Uti/promx20h
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines